{"id":"NCT01089647","sponsor":"Romaker & Associates","briefTitle":"Montelukast and Inhaled Nasal Steroid Tx in Adult Obstructive Sleep Apnea (OSA)","officialTitle":"Montelukast and Nasa ICS for Treatment of Mild Obstructive Sleep Apnea in Adults","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-09","primaryCompletion":"2014-06","completion":"2014-06","firstPosted":"2010-03-18","resultsPosted":"2018-12-03","lastUpdate":"2018-12-03"},"enrollment":34,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Obstructive Sleep Apnea"],"interventions":[{"type":"DRUG","name":"budesonide and montelukast","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"budesonide and montelukast","type":"ACTIVE_COMPARATOR"},{"label":"placebo","type":"PLACEBO_COMPARATOR"}],"summary":"In children with mild apnea combined therapy with an inhaled nasal steroid and a medication that decreased nasal congestion (montelukast) was shown to be effective. We are testing to see if this combination works in adults with mild apnea as well.","primaryOutcome":{"measure":"Number of Participants With a Decrease in the Number of Apnea and/or Hypopnea Events to <5 Per Hour of Sleep","timeFrame":"3 months","effectByArm":[{"arm":"Budesonide and Montelukast","deltaMin":5,"sd":null},{"arm":"Placebo","deltaMin":3,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"=0.946"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":6},"locations":{"siteCount":2,"countries":["United States"]},"refs":{"pmids":["31383235"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":13},"commonTop":["nosebleed","lower leg swelling"]}}